Forbes -
14 Nov 2012 22:15

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on November 5, Ironwood Pharmaceuticals Inc.'s Chief Executive Officer, Peter M. Hecht, invested $582,500.00 into 50,000 shares of IRWD, for a cost per share of $11.65. Bargain hunters tend to pay particular attention to insider buys like this one, because presumably the only reason an insider would take their hard-earned cash and use it to buy stock of the...
Share this Article